Pharmafile Logo

Moving Beyond the 10%: A New Era in Preterm Birth Prevention

July 1, 2026 | #HearFromHer #PretermBirth 

For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause of death for neonates, carrying a heavy toll of lifelong health complications, developmental disabilities, and a staggering $25 billion annual cost to the healthcare system.

- PMLiVE

Listen to the full episode here.

As discussed in the latest Hear From Her podcast, the challenge has always been prediction. “Prior to this, we had very few tools to help predict who is at risk,” explains Dr. Mollie McDonnold, a Maternal-Fetal Medicine specialist. Traditionally, doctors relied on a patient’s history of previous preterm births, but the majority of cases occur in women with no prior history.

The Biomarker Breakthrough

The conversation highlights a shift toward personalized medicine through the use of biomarkers. By analyzing proteins from the placenta via a simple blood draw early in pregnancy, clinicians can now identify high-risk patients with much greater sensitivity than traditional methods.
Listen to the full episode here.

The Power of the “Bundle”

Identification is only half the battle; prevention is the goal. Zhenya Lindgardt, CEO of Sera Prognostics, shares results from the “Prime Study,” which utilized a protocol designed with the Society for Maternal-Fetal Medicine. When high-risk women were treated with a “preventive bundle”—consisting of low-dose aspirin, vaginal progesterone, and weekly nurse check-ins—the results were “spectacular”:  

  • A 20% reduction in severe neonatal morbidity.  
  • A 52% reduction in births before 32 weeks.  
  • One out of five babies avoided the NICU entirely.

Listen to the full episode here.

 A Tailored Future

The future of maternal health lies in moving away from a “one size fits all” approach. By stratifying care, healthcare providers can funnel intensive resources—like cervical length monitoring and specialized nurse support—to those who need it most, while providing peace of mind to those at low risk. As Lindgardt notes, the goal is to ensure every pregnancy receives the specific level of care it requires to thrive.

Listen to the full episode here.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape at the American Diabetes Association’s 85th Scientific Sessions: Your Sweet Spot for Innovation!

The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the world of diabetes care! With two groundbreaking symposia, 11 dynamic...

Sharing Educational Outcomes at EHA 2025

Medscape Hematology will be at EHA 2025 to showcase the power of education impact through online abstracts, posters, and 4 symposia.

30 Years of Innovation in Education at HLTH Europe

The Medscape Education Global team will be travelling to Amsterdam for the HLTH Europe 2025 conference to showcase the power and value of CME. As pioneers in clinician education for...

Medscape Online Continuing Medical Education Led to New Diagnoses in Alzheimer’s Disease

Medscape Education has recently published a study looking at the real-world impact of online continuing medical education on Alzheimer's disease diagnosis. Read the full article here.  The study, published in...

Medscape Oncology at ASCO 2025: Driving Innovation, Education & Better Patient Outcomes

Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and the return of the Medscape Fellows Program—all aimed at educating the next...

Medscape Celebrates Eight Groundbreaking Publications at ATS 2025 International Conference

Medscape Education is proud to announce the presentation of eight innovative educational research publications at the American Thoracic Society (ATS) 2025 International Conference, held May 16–21 in San Francisco, CA....

The Future of CME in the Virtual World

The future of CME is here—and it’s personal, powerful, and primed for impact. In an era where clinician time is stretched thin, AI and digital innovation are transforming continuing medical...

Stronger Together: Medscape Education Celebrates Accomplishments in Rare Disease and Anticipates the World Health Assembly Adoption of the Resolution on Rare Diseases

Medscape Education is proud to be showcasing the power of working together in rare disease education and advocacy by co-hosting a side event at the 78th World Health Assembly in...

Intersection of Leadership and Advocacy: Driving Change Together for Women

We can’t talk about challenges to women’s reproductive health without acknowledging that we’re living in unprecedented times, say two mission-driven women’s healthcare leaders. Stephanie Sober, MD, MSHP, Global Director, Medical...

Shaping the Future of Hematology and Women’s Health

Changes in the healthcare world are likely to limit opportunities for young researchers, especially women.Three leaders in hematology — Belinda Avalos, Sarah O’Brien, and Marty Liggett — share the initiatives...